HANGZHOU DAC BIOTECHNOLOGY Co., LTD. is a clinical-stage biotechnology company dedicated to the discovery, development and manufacture of novel ADCs for the treatment of diseases with significant unmet medical needs. Since our inception in 2012, we have built end-to-end in-house capabilities spanning the ADC value chain, from discovery and preclinical research through clinical development, CMC and GMP manufacturing.